Sanofi walks away from $500M deal, leav­ing Rev­o­lu­tion alone in push­ing SHP2/KRAS com­bo

3 years ago
Deals

Ver­tex just found the next big ‘trans­for­ma­tive’ thing for the pipeline — at a biotech just down the street

3 years ago
Deals

Am­gen vet's new biotech nets $47M Se­ries A for poly­mer-based AD­Cs

3 years ago
Startups
R&D

Prim­ing ther­a­py biotech emerges from stealth with seed fund­ing — and on a hunt for part­ners

3 years ago
Financing
Startups

Prometheus moves to raise cash hours af­ter PhII da­ta leads to stock surge

3 years ago
Financing

SABCS roundup: No­var­tis shows two-year PFS in breast can­cer sub­groups; As­traZeneca re­veals more En­her­tu da­ta

3 years ago
Pharma

Big Phar­mas team up with lo­cal Sin­ga­pore or­ga­ni­za­tions to boost man­u­fac­tur­ing

3 years ago
Pharma
Manufacturing

Q&A with Gates leader: Women tak­ing on more roles in phar­ma man­u­fac­tur­ing, but still work to do

3 years ago
Manufacturing

Phar­ma rep­u­ta­tion re­tains 'halo' even as pan­dem­ic me­dia cov­er­age re­cedes — sur­vey

3 years ago
Pharma
Marketing

Suf­fer­ing in si­lence: COPD pa­tients face fre­quent symp­toms, dis­sat­is­fac­tion with meds, but don't talk to docs — ...

3 years ago
Pharma
Marketing

FDA pulls On­copep­tides' Pepax­to in­di­ca­tion, open­ing the door for dan­gling ac­cel­er­at­ed ap­proval en­force­ment

3 years ago
FDA+

With clear PhII win in IBD, Prometheus thwarts Pfiz­er com­par­isons as it fol­lows Hu­mi­ra 'play­book'

3 years ago
R&D

Avro­bio touts ear­ly clin­i­cal da­ta and plans new gene ther­a­py tri­al in 2023

3 years ago
R&D
Cell/Gene Tx

Flori­da judge dis­miss­es Zan­tac can­cer claims against GSK, oth­er phar­mas

3 years ago
Pharma
Law

Just days be­fore pre­sent­ing at ASH con­fer­ence, Syn­dax out­lines plan to raise $150M

3 years ago
Financing
R&D

Pen­ny stock pulls back on of­fer­ing up more of its shares amid ‘cur­rent mar­ket con­di­tions’

3 years ago
Financing
R&D

Neu­ro­crine's $50M bet on Idor­sia drug flames out in sec­ond PhII

3 years ago
R&D

They with­drew their IPO. Then, they broke off their SPAC merg­er. Now what?

3 years ago
Financing

Spe­cial re­port 2022: Meet 20 women blaz­ing trails in bio­phar­ma R&D

3 years ago
Special

For­mer Bridge­Bio ex­ec launch­es new an­ti-in­flam­ma­to­ry biotech with $169M, but is mum on what ex­act­ly it's do­ing

3 years ago
Financing

Ei­sai re-ups metasta­t­ic breast can­cer aware­ness cam­paign with strik­ing pa­tient pho­tographs

3 years ago
Pharma
Marketing

Glen­mark hit with warn­ing let­ter over pro­ce­dures, qual­i­ty con­trol is­sues at In­dia man­u­fac­tur­ing plant

3 years ago
Pharma
FDA+

Klick Health an­nu­al hol­i­day spot­light se­nior lone­li­ness and the pow­er of con­nec­tion

3 years ago
Pharma
Marketing

Pfiz­er and BioN­Tech look to toss Mod­er­na patent suit, call­ing claims 'unen­force­able'

3 years ago
Pharma
Coronavirus
First page Previous page 418419420421422423424 Next page Last page
A service from the Financial Times